Issues
-
Cover image
Cover Image
Cover: Image of a Drosophila central nervous system from a third-instar larva. The tissue contains numerous neural progenitor clones that are mutant for the coenzyme Q10 biosynthetic gene qless, marked with nuclear GFP (green). Also shown are the primary neural progenitors themselves, called neuroblasts (red). Loss of qless activity produces a variety of undersized clones with neuroblasts tending to be absent from the smallest ones. See Research Report by Grant et al. on page 799. - PDF Icon PDF LinkTable of contents
IN THIS ISSUE
RESEARCH HIGHLIGHT
JOURNAL CLUB
COMMUNITY NEWS
A MODEL FOR LIFE
Targeting cancer: an interview with Tyler Jacks
Tyler Jacks is one of the world’s foremost experts on mouse models of cancer and has pioneered the use of gene targeting in the mouse to construct more accurate pre-clinical models. Here, he discusses his early influences and motivation, and his hopes for the future of cancer research.
BOOK & ART REVIEW
CLINICAL PUZZLE
PRIMER
COMMENTARY
PERSPECTIVE
RESEARCH ARTICLE
Disease-specific, neurosphere-derived cells as models for brain disorders
RESEARCH REPORT
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
